Mitotane Market 2022 Over the years, mitotane has become one the preferred choices of treatment for Cushing’s syndrome and ACC. The growth of the mitotane market can be attributed to the increased incidence of patient population, which is anticipated to grow significantly in the forecast period. Furthermore, late recurrence of Cushing’s syndrome and late diagnosis and...